Style | Citing Format |
---|---|
MLA | Mohebbi N, et al.. "Vascular Microthrombosis Associated With Increased Interleukin-6. a Severe Acute Respiratory Distress Syndrome in Covid-19 Patients Treated With Tocilizumab." Advances in Respiratory Medicine, vol. 88, no. 5, 2020, pp. 468-469. |
APA | Mohebbi N, Abedini A, Lashgari R, Razavi F, Varahram M, Kiani A (2020). Vascular Microthrombosis Associated With Increased Interleukin-6. a Severe Acute Respiratory Distress Syndrome in Covid-19 Patients Treated With Tocilizumab. Advances in Respiratory Medicine, 88(5), 468-469. |
Chicago | Mohebbi N, Abedini A, Lashgari R, Razavi F, Varahram M, Kiani A. "Vascular Microthrombosis Associated With Increased Interleukin-6. a Severe Acute Respiratory Distress Syndrome in Covid-19 Patients Treated With Tocilizumab." Advances in Respiratory Medicine 88, no. 5 (2020): 468-469. |
Harvard | Mohebbi N et al. (2020) 'Vascular Microthrombosis Associated With Increased Interleukin-6. a Severe Acute Respiratory Distress Syndrome in Covid-19 Patients Treated With Tocilizumab', Advances in Respiratory Medicine, 88(5), pp. 468-469. |
Vancouver | Mohebbi N, Abedini A, Lashgari R, Razavi F, Varahram M, Kiani A. Vascular Microthrombosis Associated With Increased Interleukin-6. a Severe Acute Respiratory Distress Syndrome in Covid-19 Patients Treated With Tocilizumab. Advances in Respiratory Medicine. 2020;88(5):468-469. |
BibTex | @article{ author = {Mohebbi N and Abedini A and Lashgari R and Razavi F and Varahram M and Kiani A}, title = {Vascular Microthrombosis Associated With Increased Interleukin-6. a Severe Acute Respiratory Distress Syndrome in Covid-19 Patients Treated With Tocilizumab}, journal = {Advances in Respiratory Medicine}, volume = {88}, number = {5}, pages = {468-469}, year = {2020} } |
RIS | TY - JOUR AU - Mohebbi N AU - Abedini A AU - Lashgari R AU - Razavi F AU - Varahram M AU - Kiani A TI - Vascular Microthrombosis Associated With Increased Interleukin-6. a Severe Acute Respiratory Distress Syndrome in Covid-19 Patients Treated With Tocilizumab JO - Advances in Respiratory Medicine VL - 88 IS - 5 SP - 468 EP - 469 PY - 2020 ER - |